COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Cogent Biosciences (COGT) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Cogent Biosciences (COGT): Billionaire Stan Druckenmiller Admires Upside Potential of This Stock [Yahoo! Finance]
Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy' [Seeking Alpha]
Form ARS Cogent Biosciences, Inc. For: Dec 31
Form DEF 14A Cogent Biosciences, Inc. For: Jun 09
Form DEFA14A Cogent Biosciences, Inc.
Form 4 Cogent Biosciences, Inc. For: Apr 01 Filed by: Ferrante Karen Jean
Form 144 Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.